Extra virgin olive oil.

Beta-carotene is fat soluble and reaches the enterocyte inside bile-salt micelles, which form only when dietary lipid is present in the same meal. Olive oil supplies long-chain triacylglycerols that drive that micelle step. This is an absorption relationship, not an added effect of either compound.

Lycopene partitions into the lipid phase of a meal before it can be packaged into chylomicrons. Cooking tomato in olive oil is the traditional version of the same chemistry. The pairing changes how much is absorbed, not what lycopene does once absorbed.

Lutein needs a fat-containing meal for micellar solubilisation. An oil-based matrix is the usual formulation answer for this, and olive oil is one of the vehicles used. The claim here is about delivery.

Vitamin D3 dissolves in lipid, not water, so it is commonly suspended in an oil in softgels. Olive oil is one of the carriers used for that purpose. Taking a D3 dose with a meal containing fat follows the same logic.

Phylloquinone absorption rises when it is consumed with fat because it travels the same micellar route as other fat-soluble vitamins. Olive oil itself contributes some phylloquinone, so the pairing is both vehicle and source. Amounts vary with cultivar and processing.

Olive oil carries tocopherols as part of its unsaponifiable fraction, and supplemental vitamin E uses the same lipid-dependent absorption path. In the oil itself alpha-tocopherol slows lipid peroxidation of the unsaturated fatty acids. Adding more tocopherol to an oil-based formula is a formulation practice as much as a nutritional one.

Ascorbate sits in the aqueous phase and reduces the tocopheroxyl radical back to alpha-tocopherol at the lipid-water interface. In a formula containing an oil plus its tocopherols, that recycling step is what keeps the lipid-phase antioxidant available. This is bench redox chemistry rather than a measured clinical outcome.

CoQ10 is a large lipophilic quinone with low aqueous solubility, and oil-based suspensions are the standard way it is delivered. Olive oil functions as one such carrier. The interaction is about getting the molecule across the gut, not about a shared mechanism afterwards.

Astaxanthin is supplied in oleoresin or oil suspension because it needs a lipid phase to be absorbed. Olive oil serves that role in some formulations. Nothing here says the two act on the same target.

Curcuminoid absorption is limited first by solubility, which is why oil, phospholipid and micellar formats exist. An olive oil matrix provides the lipid phase for that step. Whether it changes anything a person notices was not measured here.

EPA and DHA are highly oxidisable, and the oleic-acid-rich, tocopherol-containing olive oil matrix is one of the lipid backgrounds used alongside them in blended oils. The two supply different fatty acid classes rather than competing for one pathway. Oxidative stability of any blend depends on storage, light and headspace oxygen.

Phenolic compounds with catechol groups, the class that includes the hydroxytyrosol derivatives in unrefined olive oil, bind ferric iron in the gut lumen and lower non-heme iron uptake. The effect is meal-specific and depends on how much phenol is present. Separating a non-heme iron dose from a large phenol load is the usual practical response.

Lecithin is an amphiphilic emulsifier used to disperse an oil phase in a water phase and to keep it dispersed. In emulsions and softgel fills it sits alongside the oil rather than acting on the body. Its presence changes droplet size, which is what governs lipid digestion rate.

Quercetin aglycone dissolves poorly in water and its absorption improves in lipid-containing matrices. Olive oil is one lipid vehicle used for polyphenol delivery. The pairing is a delivery observation, not a demonstrated combined effect.

Retinyl esters are hydrolysed and taken up from bile-salt micelles, a step that needs dietary fat. Oil carriers are standard for retinyl palmitate. Olive oil fills that role without contributing preformed vitamin A itself.